Varex Imaging (VREX) to Release Earnings on Tuesday

Varex Imaging (VREX) is scheduled to report Q4 2025 earnings on November 18th, with consensus estimates at $0.18 EPS and $219.26 million in revenue. The X-ray imaging component manufacturer, currently trading down 0.8% from its $11.92 open price, holds a $494.68 million market cap and a negative P/E ratio. Analyst ratings are mixed, ranging from "buy" to "sell" with an average "Hold" rating and a $19.50 price target, while several institutional investors have recently adjusted their positions, largely increasing stakes.

Analysis

Varex Imaging (VREX) is scheduled to report its Q4 2025 earnings on November 18th, with consensus estimates projecting $0.18 EPS and $219.26 million in revenue. The stock, currently trading down 0.8% from its $11.92 open, carries a negative P/E ratio of -3.71, indicating recent unprofitability and making the upcoming results crucial for its financial outlook. Its market capitalization stands at $494.68 million, with a beta of 0.98.

Analyst sentiment for VREX is mixed, reflected in an average "Hold" rating from MarketBeat.com, despite two "Buy" ratings and one "Sell." B. Riley recently reaffirmed a "Buy" rating and raised its price target to $16.00 from $12.00, suggesting potential upside. Conversely, Wall Street Zen downgraded its rating to "buy" from "strong-buy," and Weiss Ratings reissued a "sell" rating, highlighting divergent expert opinions.

Institutional investors have shown increased interest, with several firms like BNP Paribas, Manufacturers Life, Cerity Partners, Inceptionr LLC, and Glenmede Investment Management either boosting existing positions or initiating new ones in Q2 and Q3. Fundamentally, the company exhibits strong liquidity with a current ratio of 3.51 and a quick ratio of 1.82, alongside a manageable debt-to-equity ratio of 0.78. The stock's 50-day moving average of $11.83 is above its 200-day moving average of $9.78, potentially signaling positive technical momentum.

Key Decisions for Investors

• Investors should closely monitor Varex Imaging's Q4 2025 earnings report on November 18th, focusing on EPS and revenue figures against analyst expectations, given the current negative P/E ratio.
• Evaluate the mixed analyst ratings and the average "Hold" recommendation, weighing the bullish price target from B. Riley against the cautious stance from Weiss Ratings.
• Assess post-earnings institutional trading activity and the stock's reaction relative to its 50-day and 200-day moving averages, which currently suggest positive momentum.
• Consider the company's strong liquidity ratios (current ratio 3.51, quick ratio 1.82) and moderate debt-to-equity ratio (0.78) as fundamental strengths when evaluating long-term prospects.